New York, May 30, 2026, 17:01 (EDT)
Axon Enterprise shares closed a holiday-shortened week at $448.72, up 2.1% on Friday and about 16.5% from the prior Friday, as investors returned to the Taser maker’s artificial intelligence and counter-drone story after a sharp two-day rally. The stock rose 12.3% on Thursday and 2.1% on Friday; there was no Saturday trade, and U.S. exchanges had also shut on Monday for Memorial Day.
The timing matters. Axon heads into appearances next week at the Baird Global Consumer, Technology & Services Conference on June 2 and the William Blair Growth Stock Conference on June 4, giving management fresh chances to defend the rebound and update investors on demand.
The market’s question is plain: can Axon’s newer software, AI and drone-security businesses keep growing fast enough to offset valuation worries and uneven sentiment around high-growth technology names? AI means software that can automate tasks such as report writing and evidence review; counter-drone systems detect, track or help respond to unauthorized drones.
Axon’s most recent results are the essential backdrop. The company said first-quarter revenue rose 34% to $807 million, software and services revenue rose 35% to $355 million, AI product revenue rose more than 700%, and counter-drone product revenue rose more than 300%. Axon also lifted its full-year revenue growth forecast to 30% to 32% and kept its adjusted EBITDA margin target at 25.5%; adjusted EBITDA is a profit measure that strips out interest, taxes, depreciation and amortization, plus company adjustments.
Founder and Chief Executive Rick Smith said in the earnings release that customers face “greater transparency and higher expectations,” a pitch aimed at police agencies, courts and other public-safety buyers that are handling more video, data and reporting work. PR Newswire
The move also stood out against market and peer trading. The SPDR S&P 500 ETF rose 0.2% on Friday and the Invesco QQQ Trust gained 0.4%, while Motorola Solutions, a public-safety communications peer, fell 2.0%.
At a TD Cowen conference transcript published Saturday, analyst Andrew Sherman called Axon’s first quarter a “great quarter” and said Dedrone, Axon’s counter-drone unit, “really stood out.” Axon President Joshua Isner said governments were recognizing “how serious the threat is” around drones and security. Seeking Alpha
A recent Echodyne release carried by Axon added to that theme. Echodyne said its radar technology would support Axon Air and Dedrone products for public-safety drone operations, while Echodyne CEO Eben Frankenberg said, “Radar is the cornerstone of airspace awareness.” Axon.com
Wall Street is still not all in one camp. MarketScreener data showed a Buy consensus from 20 analysts and an average target price of $662.04, but recent recommendation changes included UBS cutting its target to $440 from $570 and Morgan Stanley cutting its target to $600 from $675 while keeping an Overweight rating.
There were also routine insider-sale disclosures in the week. A Securities and Exchange Commission filing showed Chief Legal Officer Isaiah Fields sold 2,000 shares at $400 each on May 22 and retained 52,813 shares directly after the transaction.
But the rebound leaves less room for disappointment. Axon itself lists risks including government-contract cancellations, funding pressure at law-enforcement customers, supply-chain disruption, regulation, litigation, data-security issues and pressure on expected costs or margins. A miss on any of those, or a slower take-up of AI and drone products, could quickly turn a momentum trade back into a valuation debate.
For the week ahead, investors will be listening less for slogans than for order trends, margin detail and any sign that the drone and AI businesses are moving from promising add-ons to durable revenue lines. The stock has already moved. Now the company has to make the case.
